Amanda Burke
Acute Care · Jefferson, LANPI 1982071353
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations.
Across 35 payments — averaging $95.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$498
- AbbVie$379
- Medtronic$308
- Sanofi$245
- Novo Nordisk$245
- Exact Sciences$167
- plus $2K from 14 others
What the payments were for
- Food & beverage$3,345100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 5 | $498 |
| AbbVie | 6 | $379 |
| Medtronic | 2 | $308 |
| Sanofi | 2 | $245 |
| Novo Nordisk | 2 | $245 |
| Exact Sciences | 3 | $167 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Organon | 1 | $138 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Gilead | 1 | $125 |
| Edwards Lifesciences | 1 | $125 |
| Neurelis, Inc. | 1 | $124 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $120 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $100 |
| Lilly USA, LLC | 1 | $95 |
| Boston Scientific | 1 | $75 |
| Shionogi Inc | 1 | $52 |
| Abbott | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,345 in reported general payments places this provider in the 85th percentile of 248 acute care providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 13 | $3,485 |
| Omeprazole | 104 | $1,507 |
| Ursodiol | 11 | $1,005 |
| Famotidine | 46 | $484 |
| Clarithromycin | 12 | $367 |
| Pantoprazole Sodium | 21 | $336 |
| Nystatin | 24 | $288 |
| Ondansetron OdtOndansetron | 19 | $233 |
| Potassium Chloride | 15 | $80 |
Paid to pharmacies, not to this prescriber.
Other acute care in Jefferson
- Precious HodgesLafayette$70K
- Brinton FegleyShreveport$61K
- Charles JarreauNew Orleans$40K
- Jeremy DavisShreveport$35K
- Heather MecomShreveport$17K
- Jeremy TerroLafayette$11K
- Mary HireShreveport$11K
- Jacquelyn CosterHouma$10K
- Monique YoungMetairie$10K
- Sammi SmithShreveport$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.